Real world Comparative Effectiveness and Safety of Dabigatran versus Warfarin
Real world Comparative Effectiveness and Safety of Dabigatran versus Warfarin
批准号:
266155
负责人:
Holbrook Anne M
金额:
$8.16万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-09-01 至 2014-03-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Dabigatran is the first in a series of new anticoagulants approved for atrial fibrillation (AF), which is the most common chronic heart rhythm problem in Canada and a common cause of stroke. Warfarin has been the standard anticoagulant for more than 50 ye
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving Medication Prescribing-Related Outcomes for Vulnerable Elderly In Transitions (IMPROVE-IT): A Pilot Randomized Trial
-
批准号:401511
-
项目类别:Operating Grants
-
资助金额:$14.46万
-
财政年份:2019
-
负责人:Holbrook Anne M
-
依托单位:
A Randomized Trial of Coordinated Anticoagulant Care At Hospital Discharge: A Medication Safety Priority
-
批准号:345707
-
项目类别:Operating Grants
-
资助金额:$44.56万
-
财政年份:2016
-
负责人:Holbrook Anne M
-
依托单位:
Electronic Tools to Improve Anticoagulant Therapy for Individuals and Populations
-
批准号:271671
-
项目类别:Operating Grants
-
资助金额:$7.2万
-
财政年份:2012
-
负责人:Holbrook Anne M
-
依托单位:
A National Electronic Network for Rapid Assessment of Drug Safety and Effectiveness
-
批准号:192722
-
项目类别:Operating Grants
-
资助金额:$7.21万
-
财政年份:2009
-
负责人:Holbrook Anne M
-
依托单位:
Public Opinions on the Ethics of Physician-Pharmaceutical Industry Interactions
-
批准号:186402
-
项目类别:Operating Grants
-
资助金额:$7.53万
-
财政年份:2009
-
负责人:Holbrook Anne M
-
依托单位:
Developing a National Electronic Network in Primary Care to Advance Drug Safety and Effectiveness
-
批准号:192241
-
项目类别:Operating Grants
-
资助金额:$6.94万
-
财政年份:2009
-
负责人:Holbrook Anne M
-
依托单位: